For years, microbiologists have been interested in fully automating single-cell isolation from complex sample suspension in order to characterize unknown species. The new B.SIGHT has been designed to tackle this challenge efficiently and reliably.
“The new instrument provides more automation, faster processing speeds, higher resolution and precise dispensing,” said Dr Hussein Hamzeh, the B.SIGHT’s Product Manager. He also explained that, in addition to optimizing workflows, the B.SIGHT follows CYTENA’s philosophy on customer-conscious product design. “Researchers using the B.SIGHT not only will be able to accelerate microorganism isolation workflows but also significantly reduce plastic waste.”
CYTENA believes the new B.SIGHT will accelerate and automate microbial cloning workflows in Pharma and Biotech companies. It will also revolutionize the microbiome field by enabling scientists to streamline their microbiome work and accelerate their path towards transformative medicine.
For more information, visit: https://www.cytena.com